← Back to Search

End-of-Life Conversation Game for Cancer

N/A
Waitlist Available
Led By Lauren Van Scoy, MD
Research Sponsored by Milton S. Hershey Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults (> 18 years old)
Be an individual diagnosed with breast, lung, or genitourinary/prostate cancer as verified by primary oncologist or is the chosen caregiver for a participant with those cancers
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately post-intervention
Awards & highlights

Study Summary

This trial studies how the game "Hello" can help people with cancer and their loved ones plan end-of-life care decisions. Players will complete surveys and participate in focus groups to assess the game's effectiveness.

Who is the study for?
This trial is for adults over 18 with breast, lung, or genitourinary cancers treated at Penn State Health. Participants can also be caregivers chosen by these patients. All must speak and read English.Check my eligibility
What is being tested?
The study tests the 'Hello' game as a tool for advance care planning in cancer patients. It examines necessary modifications to the game and compares different delivery models for recruitment efficiency.See study design
What are the potential side effects?
Since this intervention involves a conversation game rather than medical treatment, traditional physical side effects are not expected; however, emotional distress due to discussing end-of-life topics may occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 years old.
Select...
I have been diagnosed with breast, lung, or prostate cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Experiences and perceptions of intervention
Secondary outcome measures
Acceptability of Intervention Measure
Advance Care Planning Engagement Measure
Advance Care Planning Surrogate Decision Maker Engagement Measure
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Game participantsExperimental Treatment1 Intervention
All participants will engage in playing the end-of-life conversation game called "Hello", which involves answering open-ended questions about medical decision making and end-of-life issues.

Find a Location

Who is running the clinical trial?

Milton S. Hershey Medical CenterLead Sponsor
492 Previous Clinical Trials
2,798,808 Total Patients Enrolled
13 Trials studying Breast Cancer
591 Patients Enrolled for Breast Cancer
Lauren Van Scoy, MDPrincipal InvestigatorPenn State College of Medicine
1 Previous Clinical Trials
93 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available slots in this clinical experiment for participants?

"Affirmative. The information hosted on clinicaltrials.gov implies that this experimental research is actively recruiting participants, with the first posting being made on October 1st 2023 and a recent update occurring on November 10th of the same year. 16 volunteers are needed from one site for completion of the study."

Answered by AI

Are there any restrictions on how many individuals are eligible to participate in this research?

"Affirmative. According to clinicaltrials.gov, the trial which was initially uploaded on October 1st 2023 is actively enrolling participants; its most recent update being November 10th 2023. 16 patients are needed at one medical centre."

Answered by AI
~9 spots leftby Apr 2025